Latest News about BEAM
Recent news which mentions BEAM
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday
April 21, 2025
From Benzinga
Beam Therapeutics Presents Biomarker Data For BEAM-302 Gene Therapy For Inherited Disease
April 07, 2025
From Benzinga
From Benzinga
Cathie Wood Just Made A Bold Move—Why She Spent Over $65M On Tesla, Robinhood, And Coinbase 'As The Market Crashed'
April 04, 2025
From Benzinga
From Benzinga
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen
March 22, 2025
From Benzinga
From Benzinga
Cathie Wood Backs Promising Genomics Stock
March 05, 2025
From Wall Street Pit
Cathie Wood's Bold Move: 8 Straight Days Of Buying Beam Therapeutics As Stock Soars 14%
March 04, 2025
From Benzinga
Cathie Wood's Ark Invest Loads Up On Beam Therapeutics, Nu Holdings: Offloads MercadoLibre, Adaptive Biotechnologies
February 22, 2025
From Benzinga
Cathie Wood's Ark Invest Loads Up On Iridium, Twist Bioscience, Offloads Roku: Here Are Key Ark Trades This Friday
February 15, 2025
From Benzinga
Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday
February 14, 2025
From Benzinga
Demystifying Beam Therapeutics: Insights From 4 Analyst Reviews
January 29, 2025
Tickers
BEAM
From Benzinga
Beam Therapeutics Unveils New Safety, Efficacy Data From Sickle Cell Disease Candidate, Stock Gains
December 09, 2024
From Benzinga
From Benzinga
Editas Medicine Downgraded: Analyst Sees Limited Near-Term Catalysts
November 25, 2024
From Benzinga
Breaking Down Beam Therapeutics: 5 Analysts Share Their Views
November 06, 2024
Tickers
BEAM
From Benzinga
From Benzinga
Gene Therapy Developer Beam Therapeutics Reports One Patient Death In Early-Stage Sickle Cell Disease Trial
November 05, 2024
From Benzinga
Deep Dive Into Beam Therapeutics Stock: Analyst Perspectives (6 Ratings)
September 11, 2024
Tickers
BEAM
From Benzinga
A Closer Look at 5 Analyst Recommendations For Beam Therapeutics
August 22, 2024
Tickers
BEAM
From Benzinga
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
August 14, 2024
From Benzinga
3 Gene Editing Stocks with Potential to Transform Medicine
August 09, 2024
From InvestorPlace
Tickers
BEAM
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.